Pharma firm GSK has agreed to buy liver disease medicine efimosfermin from US firm Boston Pharmaceuticals, for up to $2 billion in cash. The sum will consist of a $1.2 billion upfront payment and ...

Speaking to Yvonne Man during a fireside chat at Bloomberg's New Voices Hong Kong 2025 launch event, Lo discussed how they're navigating market volatility amid the trade tensions. (Source ...